Anti-migraine activity of freeze-dried latex obtained from Calotropis gigantea Linn
Sign Up to like & getrecommendations! Published in 2022 at "Environmental Science and Pollution Research"
DOI: 10.1007/s11356-021-17810-x
Abstract: Migraine which is characterized by a pulsating headache affected an estimated population of 12% worldwide. Herbal products like latex derived from Calotropis gigantea R. Br. (Asclepiadaceae) are a representative intervention to treat migraine traditionally. However,… read more here.
Keywords: gigantea; freeze; anti migraine; calotropis gigantea ... See more keywords
Identification and quantification of the quality markers and anti-migraine active components in Chuanxiong Rhizoma and Cyperi Rhizoma herbal pair based on chemometric analysis between chemical constituents and pharmacological effects.
Sign Up to like & getrecommendations! Published in 2019 at "Journal of ethnopharmacology"
DOI: 10.1016/j.jep.2019.112228
Abstract: ETHNOPHARMACOLOGICAL RELEVANCE Chuanxiong Rhizoma and Cyperi Rhizoma (CRCR), an ancient and classic herbal pair, has been used in herbal medicines for treating migraine, but its effective components are not clear. AIM OF THE STUDY The… read more here.
Keywords: analysis; anti migraine; quality markers; chemical constituents ... See more keywords
Tibetan medicine Ru-yi-Zhen-bao Pills exhibits anti-migraine effect through mediating PAG anti-nociceptive channel.
Sign Up to like & getrecommendations! Published in 2019 at "Journal of ethnopharmacology"
DOI: 10.1016/j.jep.2019.112437
Abstract: ETHNOPHARMACOLOGICAL RELEVANCE Migraine is a disabling neurovascular disorder, which increases risk of cardiovascular events and is a social burden worldwide. The present first-line anti-migraine medications can cause overwhelming side-effects, of which one includes the onset… read more here.
Keywords: medicine; anti migraine; group; bao pills ... See more keywords
The anti‐migraine component of butterbur extracts, isopetasin, desensitizes peptidergic nociceptors by acting on TRPA1 cation channel
Sign Up to like & getrecommendations! Published in 2017 at "British Journal of Pharmacology"
DOI: 10.1111/bph.13917
Abstract: The mechanism of the anti‐migraine action of extracts of butterbur [Petasites hybridus (L.) Gaertn.] is unknown. Here, we investigated the ability of isopetasin, a major constituent of these extracts, to specifically target TRPA1 channel and… read more here.
Keywords: isopetasin desensitizes; butterbur extracts; extracts isopetasin; anti migraine ... See more keywords
Current Status at Drug Delivery Approaches and Assay of Anti-Migraine Drugs.
Sign Up to like & getrecommendations! Published in 2020 at "Current drug delivery"
DOI: 10.2174/1567201817666200508094204
Abstract: Migraine is a chronic, painful, neurological disorder that affects approximately 15% of the population worldwide. It is a form of neurovascular headache: a disorder in which neural events result in the dilation of blood vessels… read more here.
Keywords: drug; drug delivery; status; anti migraine ... See more keywords
Natural products for migraine: Data-mining analyses of Chinese Medicine classical literature
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Pharmacology"
DOI: 10.3389/fphar.2022.995559
Abstract: Background: Treatment effect of current pharmacotherapies for migraine is unsatisfying. Discovering new anti-migraine natural products and nutraceuticals from large collections of Chinese medicine classical literature may assist to address this gap. Methods: We conducted a… read more here.
Keywords: natural products; medicine classical; anti migraine; chinese medicine ... See more keywords
Pharmacokinetics, Pharmacodynamics and Drug–Drug Interactions of New Anti-Migraine Drugs—Lasmiditan, Gepants, and Calcitonin-Gene-Related Peptide (CGRP) Receptor Monoclonal Antibodies
Sign Up to like & getrecommendations! Published in 2020 at "Pharmaceutics"
DOI: 10.3390/pharmaceutics12121180
Abstract: In the last few years, there have been significant advances in migraine management and prevention. Lasmiditan, ubrogepant, rimegepant and monoclonal antibodies (erenumab, fremanezumab, galcanezumab, and eptinezumab) are new drugs that were launched on the US… read more here.
Keywords: monoclonal antibodies; drug drug; anti migraine; drug ... See more keywords